Stock listing
Oslo:PHO Photocure ASA Aksje
Home listing (Oslo) of Photocure ASA
Follow Photocure ASA into a list and get an email when it puts out news.
Share price · OSL:PHO
41.25 NOK -0.45 (-1.1%)
Close on Nov 20, 2026
- Day range
- 40.85 – 41.55 NOKNov 20, 2026
- Volume
- 46,691 sharesNov 20, 2026
- Market cap
- 1.11B NOKAt the close on Nov 20, 2026 · price × 26.92M shares outstanding
- 52-week range
- 40.40 – 79.80 NOKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 3.08M NOKMedian day 48,666 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Oslo:PHO · Home | 41.25 NOK | -0.45 (-1.1%) | 46,691 | 41.35 | 41.55 | 40.85 | 41.70 | Close on Nov 20, 2026 |
| LSE:0IMT | 40.85 NOK | -1.20 (-2.9%) | 66 | 41.10 | 41.10 | 40.85 | 42.05 | Close on Nov 17, 2026 |
| Frankfurt:PHS | €3.885 EUR | +0.085 (+2.2%) | — | €3.885 | €3.885 | €3.885 | €3.80 | Close on Nov 20, 2026 |
| Stuttgart:PHS | €3.75 EUR | -0.13 (-3.4%) | — | €3.88 | €3.89 | €3.695 | €3.88 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OSL:PHO · NOK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 41.25 | -0.45 | -1.1% | 41.35 | 41.55 | 40.85 | 46,691 | |
| 41.70 | +1.30 | +3.2% | 40.75 | 41.80 | 40.50 | 74,387 | |
| 40.40 | -1.65 | -3.9% | 42.05 | 42.05 | 40.40 | 115,609 | |
| 42.05 | -0.80 | -1.9% | 43.05 | 43.45 | 42.00 | 42,251 | |
| 42.85 | +0.95 | +2.3% | 41.50 | 43.20 | 41.50 | 75,709 | |
| 41.90 | -0.05 | -0.1% | 42.00 | 42.15 | 41.55 | 94,840 | |
| 41.95 | +0.15 | +0.4% | 42.00 | 42.65 | 41.60 | 96,748 | |
| 41.80 | -0.30 | -0.7% | 42.90 | 42.90 | 41.65 | 99,801 | |
| 42.10 | -2.50 | -5.6% | 44.60 | 44.85 | 41.50 | 199,502 | |
| 44.60 | +0.20 | +0.5% | 43.25 | 44.60 | 43.05 | 126,301 | |
| 44.40 | -0.55 | -1.2% | 45.10 | 45.70 | 44.30 | 57,114 | |
| 44.95 | -0.20 | -0.4% | 45.80 | 45.80 | 44.50 | 86,412 | |
| 45.15 | -0.70 | -1.5% | 45.30 | 45.70 | 44.90 | 77,582 | |
| 45.85 | -0.60 | -1.3% | 46.45 | 46.70 | 45.65 | 80,367 | |
| 46.45 | -0.25 | -0.5% | 46.85 | 46.85 | 45.55 | 75,384 | |
| 46.70 | -0.80 | -1.7% | 47.50 | 47.90 | 46.40 | 133,104 | |
| 47.50 | -2.50 | -5.0% | 49.40 | 50.70 | 47.20 | 269,590 | |
| 50.00 | +0.40 | +0.8% | 49.85 | 50.60 | 48.75 | 142,661 | |
| 49.60 | +0.60 | +1.2% | 48.75 | 49.85 | 48.75 | 24,245 | |
| 49.00 | -0.30 | -0.6% | 49.30 | 49.65 | 48.60 | 30,632 | |
| 49.30 | -1.20 | -2.4% | 50.00 | 50.50 | 48.95 | 22,917 | |
| 50.50 | +0.40 | +0.8% | 50.00 | 50.80 | 49.85 | 29,033 | |
| 50.10 | +0.15 | +0.3% | 50.50 | 50.50 | 49.30 | 21,186 | |
| 49.95 | +0.20 | +0.4% | 49.05 | 50.00 | 49.00 | 30,984 | |
| 49.75 | +0.50 | +1.0% | 49.50 | 50.30 | 49.30 | 29,517 | |
| 49.25 | -0.35 | -0.7% | 48.90 | 49.35 | 48.90 | 23,611 | |
| 49.60 | +0.55 | +1.1% | 49.40 | 49.80 | 49.30 | 21,880 | |
| 49.05 | -0.45 | -0.9% | 49.70 | 50.00 | 48.80 | 33,669 | |
| 49.50 | +0.10 | +0.2% | 49.85 | 50.40 | 48.80 | 40,090 | |
| 49.40 | +0.90 | +1.9% | 49.10 | 49.80 | 48.90 | 63,510 | |
| 48.50 | -1.00 | -2.0% | 49.50 | 49.70 | 48.35 | 28,707 | |
| 49.50 | +1.30 | +2.7% | 48.40 | 50.00 | 48.10 | 60,667 | |
| 48.20 | +0.10 | +0.2% | 48.40 | 49.00 | 48.10 | 43,588 | |
| 48.10 | -0.90 | -1.8% | 49.00 | 49.30 | 48.10 | 39,171 | |
| 49.00 | +0.30 | +0.6% | 48.55 | 49.50 | 48.50 | 30,421 | |
| 48.70 | -1.60 | -3.2% | 49.35 | 50.00 | 48.55 | 109,917 | |
| 50.30 | +0.10 | +0.2% | 51.00 | 51.00 | 50.00 | 23,596 | |
| 50.20 | +1.20 | +2.4% | 49.00 | 50.90 | 49.00 | 85,287 | |
| 49.00 | -0.80 | -1.6% | 49.60 | 50.30 | 48.80 | 52,679 | |
| 49.80 | -1.00 | -2.0% | 50.80 | 50.90 | 47.10 | 182,742 | |
| 50.80 | -1.10 | -2.1% | 51.90 | 51.90 | 50.70 | 48,584 | |
| 51.90 | +0.10 | +0.2% | 52.20 | 52.20 | 51.30 | 34,158 | |
| 51.80 | -1.00 | -1.9% | 53.10 | 53.10 | 51.60 | 31,023 | |
| 52.80 | +1.10 | +2.1% | 52.20 | 53.10 | 51.60 | 37,508 | |
| 51.70 | -0.30 | -0.6% | 52.10 | 52.10 | 51.40 | 29,298 | |
| 52.00 | +0.40 | +0.8% | 51.10 | 52.40 | 51.10 | 19,444 | |
| 51.60 | +0.50 | +1.0% | 50.70 | 52.60 | 50.70 | 60,082 | |
| 51.10 | -0.40 | -0.8% | 50.70 | 51.30 | 50.60 | 31,977 | |
| 51.50 | -0.40 | -0.8% | 52.00 | 52.30 | 51.10 | 62,199 | |
| 51.90 | -1.30 | -2.4% | 53.00 | 53.20 | 51.90 | 44,099 | |
| 53.20 | -0.10 | -0.2% | 53.60 | 53.60 | 52.80 | 32,881 | |
| 53.30 | -0.20 | -0.4% | 53.90 | 53.90 | 53.00 | 45,781 | |
| 53.50 | 0.00 | 0.0% | 53.50 | 54.00 | 53.20 | 62,593 | |
| 53.50 | 0.00 | 0.0% | 53.40 | 54.20 | 53.40 | 40,996 | |
| 53.50 | -0.40 | -0.7% | 53.80 | 54.20 | 53.00 | 48,748 | |
| 53.90 | +0.40 | +0.7% | 53.80 | 54.30 | 53.40 | 21,162 | |
| 53.50 | -0.30 | -0.6% | 53.90 | 54.30 | 52.70 | 97,323 | |
| 53.80 | -0.70 | -1.3% | 54.30 | 54.40 | 53.80 | 38,116 | |
| 54.50 | -1.30 | -2.3% | 56.80 | 56.80 | 54.50 | 62,650 | |
| 55.80 | -0.40 | -0.7% | 56.80 | 56.80 | 55.40 | 62,724 | |
| 56.20 | +1.70 | +3.1% | 54.70 | 56.50 | 54.30 | 102,351 | |
| 54.50 | +0.50 | +0.9% | 54.60 | 54.80 | 53.80 | 40,175 | |
| 54.00 | 0.00 | 0.0% | 54.00 | 54.10 | 53.50 | 40,737 | |
| 54.00 | -0.10 | -0.2% | 54.50 | 54.80 | 53.70 | 66,967 | |
| 54.10 | 0.00 | 0.0% | 53.90 | 54.30 | 53.60 | 61,351 | |
| 54.10 | +0.10 | +0.2% | 54.40 | 55.50 | 54.10 | 54,007 |
Splits
1 split · OSL:PHO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 47-for-46 | Split |
- Ticker
- Oslo:PHO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Oslo
- Currency
- NOK
What changed lately
Latest news release · Aug 17, 2026
Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II
Latest earnings call · Oct 28, 2026
Photocure (Oslo:PHO) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 28, 2026
Q3 2026 Earnings Presentation
Earnings · 25 slides
Latest news
Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II
Aug 17, 2026
Closed 57.50 (+1.8%) on Aug 17, 2026
Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.
Aug 11, 2026
Closed 52.10 (-1.0%) on Aug 11, 2026
Photocure ASA - Share option grant to members of the board of directors
Aug 7, 2026
Closed 52.60 (+2.1%) on Aug 10, 2026
Photocure ASA: Results for the second quarter of 2026
Jul 29, 2026
Closed 54.10 (-4.8%) on Jul 29, 2026
Photocure initiates arbitration in partial milestone payment case with Asieris Pharmaceuticals
Jul 23, 2026
Closed 56.40 (+0.2%) on Jul 23, 2026
Photocure ASA - Share option grant
Jul 14, 2026
Closed 57.80 (-2.0%) on Jul 14, 2026
Photocure ASA - CFO transition
Jun 30, 2026
Closed 59.30 (-1.3%) on Jun 30, 2026
Photocure ASA: Annual general meeting held
Jun 26, 2026
Closed 60.10 (-1.2%) on Jun 29, 2026
Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer
Jun 8, 2026
Closed 57.40 (-1.4%) on Jun 9, 2026
Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics
Jun 4, 2026
Closed 58.90 (-3.3%) on Jun 5, 2026
Photocure ASA on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 21 in the last 12 months · 29 in all · newest Aug 17, 2026 · oldest 2025
- Calls
- 12 calls with a replay · 12 with a transcript · latest Oct 28, 2026
- Decks
- 119 decks · latest Oct 28, 2026
Where Photocure ASA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Oslo:PHO · Home listing · This page | Oslo | Norway | NOK |
| OTC:PHCUF | OTC | United States | USD |
| LSE:0IMT | LSE | United Kingdom | NOK |
| LS Exchange:931150 | LS Exchange | Germany | EUR |
| gettex:PHS | gettex | Germany | EUR |
| Lang & Schwarz:931150 | Lang & Schwarz | Germany | EUR |
| Stockholm:PHOO | Stockholm | Sweden | NOK |
| Aquis:PHOO | Aquis | United Kingdom | NOK |
| Aquis:PHOO | Aquis | United Kingdom | NOK |
| Frankfurt:PHS | Frankfurt | Germany | EUR |
| Dusseldorf:PHS | Dusseldorf | Germany | EUR |
| Stuttgart:PHS | Stuttgart | Germany | EUR |
| Turquoise:PHOO | Turquoise | United Kingdom | NOK |
Valuation
P/E 22.9× against a median of 32.3×: 3rd lowest of 7 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- 947.9M NOK
- P/E
- 22.9×
- EV/sales
- 1.4×
- EV/EBITDA
- 6.1×
- Price/book
- 1.9×
- Gross margin
- 93.9%
- Operating margin
- 14.9%
- Net margin
- 7.1%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Photocure ASA · OSL:PHO | US$113.9M | US$97.23M | 22.9× | 1.4× | 6.1× | 1.9× | 7.1% | 0.0× | n/a |
| Bioventix PLC · LSE:BVXP | US$133.3M | US$126.3M | 13.4× | 7.4× | 9.7× | 9.2× | 57.8% | 0.0× | n/a |
| Curiosis, Inc. · KRX:494120 | US$131.1M | US$117.6M | n/a | 18.7× | n/a | 7.1× | −93.3% | 0.0× | n/a |
| Bioneer Corporation · KRX:064550 | US$127.6M | US$107.1M | n/a | 0.4× | 10.0× | 0.8× | −1.9% | 0.3× | n/a |
| Fine Foods & Pharmaceuticals N.T.M. SpA · MIL:FF | US$123.5M | US$174.6M | 11.1× | 0.6× | 4.6× | 0.8× | 4.0% | 0.6× | n/a |
| Burning Rock Biotech Ltd. · NASDAQ:BNR | US$116.7M | US$60.54M | n/a | 0.8× | n/a | 1.6× | −13.6% | 0.1× | 1.51 |
| BIODYNE Co., Ltd. · KRX:314930 | US$115.0M | US$104.0M | 182× | 19.9× | 70.7× | 3.5× | 12.1% | 0.0× | n/a |
| ArcticZymes Technologies ASA · OSL:AZT | US$108.4M | US$80.84M | 66.1× | 6.2× | 24.6× | 3.0× | 12.7% | 0.0× | n/a |
| NanoenTek, Inc. · KRX:039860 | US$107.8M | US$71.26M | 24.8× | 2.2× | 17.4× | 1.5× | 13.3% | 0.0× | n/a |
| BICO Group AB Class B · OMXSTO:BICO | US$102.7M | US$90.50M | n/a | 0.6× | 2.1× | 0.8× | −28.3% | 0.3× | n/a |
| Devyser Diagnostics AB · OMXSTO:DVYSR | US$99.24M | US$94.86M | 39.9× | 3.8× | 17.5× | 2.6× | 10.0% | 0.1× | n/a |
| Median of the others | US$115.8M | US$99.43M | 32.3× | 3.0× | 13.7× | 2.1× | 7.0% | 0.1× | 1.51 |
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 75.00 NOK · Analysts' mean
- EPS, year to Dec 2026
- 0.68 · 1 analyst
- Revenue, year to Dec 2026
- 696M · 2 analysts
Events
- Next results
- Feb 17, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Photocure (Oslo:PHO) Q3 2026 Earnings Call | Wed, Oct 28, 2026 · 9:00 AM ET | Replay |
| Photocure (Oslo:PHO) Q2 2026 Earnings Call | Wed, Jul 29, 2026 · 8:00 AM ET | Replay |
| Photocure (Oslo:PHO) Q1 2026 Earnings Call | Thu, May 07, 2026 · 8:00 AM ET | Replay |
| Photocure (Oslo:PHO) Q4 2025 Earnings Call | Wed, Feb 18, 2026 · 8:00 AM ET | Replay |
| Photocure (Oslo:PHO) Q3 2025 Earnings Call | Wed, Oct 29, 2025 · 9:00 AM ET | Replay |
| Photocure (Oslo:PHO) Q2 2025 Earnings Call | Wed, Jul 30, 2025 · 8:00 AM ET | Replay |
| Photocure (Oslo:PHO) Q1 2025 Earnings Call | Thu, May 08, 2025 · 8:00 AM ET | Replay |
| Photocure (Oslo:PHO) Q4 2024 Earnings Call | Wed, Feb 19, 2025 · 8:00 AM ET | Replay |
| Photocure (Oslo:PHO) Q3 2024 Earnings Call | Wed, Nov 13, 2024 · 8:00 AM ET | Replay |
| Photocure (Oslo:PHO) Q2 2024 Earnings Call | Wed, Aug 07, 2024 · 8:00 AM ET | Replay |
All 12 calls
| Call | When | Status |
|---|---|---|
| Photocure (Oslo:PHO) Q1 2024 Earnings Call | Sat, May 25, 2024 · 8:00 AM ET | Replay |
| Photocure (Oslo:PHO) Q1 2023 Earnings Call | Wed, May 10, 2023 · 9:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 28, 2026 · After close | −1.7% |
| Q2 2026 | Jul 29, 2026 · Before open | −4.8% |
| Q1 2026 | May 7, 2026 · Before open | +0.5% |
| Q4 2025 | Feb 18, 2026 · Before open | +1.0% |
| Q3 2025 | Oct 29, 2025 · Before open | +1.7% |
| Q2 2025 | Jul 30, 2025 · Before open | +11.0% |
| Q1 2025 | May 8, 2025 · Before open | −4.6% |
| Q4 2024 | Feb 19, 2025 · Before open | −7.9% |
| Q3 2024 | Nov 13, 2024 · Before open | −2.8% |
| Q2 2024 | Aug 7, 2024 · Before open | +0.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 15, 2024 · Before open | −4.1% |
| Q4 2023 | Feb 21, 2024 · Before open | −6.8% |
| Q3 2023 | Nov 8, 2023 · Before open | +0.7% |
| Q2 2023 | Aug 9, 2023 · Before open | −2.5% |
| Q1 2023 | May 10, 2023 · Before open | −5.2% |
| Q4 2022 | Feb 23, 2023 · Before open | −16.7% |
| Q3 2022 | Nov 2, 2022 · Before open | +7.3% |
| Q2 2022 | Aug 10, 2022 · Before open | −2.5% |
| Q1 2022 | May 11, 2022 · Before open | −3.2% |
| Q4 2021 | Feb 23, 2022 · Before open | +6.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 25 slides | Oct 28, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 24 slides | Jul 29, 2026 |
| Merger or Acquisition (June 2026) | Merger or acquisition | 17 slides | Jun 4, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 27 slides | May 7, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 27 slides | Feb 18, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 21 slides | Oct 29, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 20 slides | Jul 30, 2025 |
| Investor Presentation (July 2025) | Investor deck | 16 slides | July 2025 |
| Q1 2025 Earnings Presentation | Earnings | 20 slides | May 8, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 22 slides | Feb 19, 2025 |
Show 50 decks
This page holds 50 of 119 decks. Open Decks
Financials
Annual, in NOK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 532.6M | 525.4M | 500.7M | 393.1M | 360.5M | 256.5M | 281.6M | 181.5M | 150.9M | 143.6M |
| Cost of revenue | 42.0M | 30.7M | 26.1M | 22.7M | 24.1M | 18.5M | 22.5M | 17.1M | 12.0M | 9.34M |
| Gross profit | 490.6M | 494.7M | 474.5M | 370.4M | 336.5M | 238.0M | 259.0M | 164.4M | 138.9M | 134.3M |
| Research and development | 402.0K | 3.63M | 2.07M | 3.34M | 4.32M | 13.8M | 13.6M | 19.1M | 32.6M | 23.0M |
| Selling, general and administrative | 363.7M | 354.9M | 334.9M | 303.4M | 259.9M | 187.8M | 148.7M | 121.3M | 96.4M | 79.9M |
| Operating income | -743.0K | 20.4M | 27.8M | -49.0M | -5.83M | -13.3M | 42.7M | -37.9M | -45.2M | -15.9M |
| Depreciation and amortization | 29.5M | 28.8M | 27.7M | 24.4M | 24.1M | 19.3M | 16.2M | 13.2M | 12.1M | 7.85M |
| EBITDA | 28.7M | 49.2M | 55.5M | -24.6M | 18.3M | 5.95M | 59.0M | -24.7M | -33.1M | -8.01M |
| Interest expense | 33.6M | 36.9M | 41.2M | 30.6M | 34.8M | 7.03M | 0 | 0 | 0 | 0 |
| Income before tax | -16.7M | 8.39M | 9.74M | -71.1M | -31.7M | -33.2M | 45.9M | -36.7M | -41.6M | 12.8M |
| Income tax | -15.2M | 11.7M | 8.76M | 723.0K | -759.0K | -10.8M | 14.1M | -6.00K | -6.88M | -22.5M |
| Net income | -1.52M | -3.34M | 979.0K | -71.9M | -30.9M | -22.4M | 31.8M | -36.7M | -34.7M | 35.3M |
| Earnings per share, basic | -0.06 | -0.19 | 0.04 | -2.66 | -115.00 | -0.90 | 1.46 | -1.70 | -1.61 | 1.64 |
| Earnings per share, diluted | -0.06 | -0.19 | 0.04 | -2.66 | -115.00 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 238.9M | 293.9M | 259.5M | 268.1M | 322.9K | 329.5M | 121.2M | 102.5M | 125.3M | 165.3M |
| Short-term investments | 79.1M | 101.0M | 141.7M | |||||||
| Receivables | 74.9M | 66.9M | 59.7M | 47.2M | 48.0M | 43.8M | 45.1M | 32.3M | 26.7M | 29.0M |
| Inventory | 44.4M | 39.5M | 37.2M | 26.5M | 27.5M | 29.7M | 16.4M | 18.6M | 19.6M | 17.5M |
| Current assets | 385.3M | 424.0M | 372.4M | 358.2M | 413.2M | 412.2M | 186.9M | 153.4M | 175.6M | 211.8M |
| Property, plant and equipment | 42.2M | 36.2M | 33.5M | 32.5M | 33.6M | 5.79M | 9.05M | 2.14M | 1.27M | 1.66M |
| Goodwill | 144.0M | 144.0M | 144.0M | 144.0M | 144.0M | 144.0M | ||||
| Total assets | 706.6M | 739.1M | 712.0M | 719.0M | 789.6M | 776.0M | 257.4M | 231.2M | 263.1M | 285.9M |
| Accounts payable | 30.0M | 19.4M | 19.7M | 21.3M | 23.6M | 23.3M | 5.12M | 10.2M | 15.1M | 9.91M |
| Current liabilities | 110.9M | 103.9M | 83.1M | 104.1M | 113.6M | 79.8M | 38.7M | 52.5M | 40.3M | 30.1M |
| Long-term debt | 100.1M | 117.1M | 0 | 0 | 12.5M | 37.5M | ||||
| Total debt | 15.4M | 15.8M | 14.0M | 27.4M | 36.6M | 53.9M | 6.95M | |||
| Total liabilities | 222.3M | 237.4M | 229.1M | 256.3M | 287.0M | 267.9M | 48.8M | 54.9M | 45.0M | 33.9M |
| Shareholders' equity | 484.2M | 501.7M | 482.8M | 462.7M | 502.6M | 508.1M | 208.6M | 176.3M | 218.1M | 251.9M |
| Shares outstanding | 26.6M | 27.1M | 27.1M | 27.1M | 27.1M | 24.8M | 21.8M | 21.6M | 21.6M | 21.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 31.7M | 76.8M | 48.3M | -2.02M | 23.9M | 15.6M | 20.7M | -24.1M | -23.6M | 19.2M |
| Capital spending | -21.7M | -11.4M | -12.3M | -3.61M | -3.70M | -1.60M | -1.24M | -2.19M | -18.6M | -22.1M |
| Free cash flow | 9.98M | 65.3M | 36.0M | -5.63M | 20.2M | 14.0M | 19.4M | -26.3M | -42.2M | -2.91M |
| Cash from investing | -9.46M | 1.42M | -594.0K | -1.46M | -1.90M | -166.2M | 610.0K | -1.06M | -16.3M | 13.9M |
| Cash from financing | -77.2M | -43.8M | -56.3M | -51.3M | -34.0M | 360.2M | -2.78M | 2.65M | 2.65M | 2.13M |
| Share buybacks | -29.7M | 0 | 7.58M | 13.9M | 314.7M | 614.0K | -377.0K | 0 | 3.40M | |
| Change in cash | -55.0M | 34.4M | -8.57M | -54.8M | -12.0M | 209.6M | 18.5M | -22.5M | -39.9M | 35.2M |
Cap table
Built by 6ix from Photocure ASA’s releases
- Common shares
- 26,916,610
- Fully diluted
- 26,916,610
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 26,916,610 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 26,916,610 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Erik Dahl | Until Jun 30, 2026 · Past |
Log in to ask 6ix AI your own questions about Photocure ASA.